LOGIN (VIA WILEY ONLINE LIBRARY)
Question:What are the effects of opioid substitution therapy and needle syringe programs for preventing hepatitis C transmission in people who inject drugs?
THIS CLINICAL ANSWER IS NEW Published Online: 4 APR 2018
EXCERPT of full Clinical Answer
This Cochrane Clinical Answer evaluates opioid substitution therapy and needle syringe programs for preventing hepatitis C transmission in people who inject drugs.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
Are you a COCHRANE CLINICAL ANSWERS subscriber?
SUBSCRIBE NOW to read the full answer
A subscription to THE COCHRANE LIBRARY is required.
Sign in:
FORGOT PASSWORD ?Other login options:
Browse Clinical Answers
- Allergy & intolerance
- Blood disorders
- Cancer
- Child health
- Complementary & alternative medicine
- Consumer & communication strategies
- Dentistry & oral health
- Developmental, psychosocial & learning problems
- Ear, nose & throat
- Effective practice & health systems
- Endocrine & metabolic
- Eyes & vision
- Fertility
- Gastroenterology & hepatology
- Genetic disorders
- Gynecology
- Health & safety at work
- Heart & circulation
- Infectious disease
- Kidney disease
- Lungs & airways
- Mental health
- Neonatal care
- Neurology
- Nutrition
- Orthopedics & trauma
- Pain & anesthesia
- Pregnancy & childbirth
- Public health
- Rheumatology
- Skin disorders
- Tobacco, drugs & alcohol
- Urology
- Wounds